These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Collecting of the news]. Sirtori C Minerva Med; 1974 Nov; 65(85 Suppl):5-7. PubMed ID: 4444797 [No Abstract] [Full Text] [Related]
29. Stuttering: a brief review. Lawrence M; Barclay DM Am Fam Physician; 1998 May; 57(9):2175-8. PubMed ID: 9606307 [TBL] [Abstract][Full Text] [Related]
30. Beliefs and behavioural intentions towards pharmacotherapy for stuttering: A survey of adults who stutter. McGroarty A; McCartan R J Commun Disord; 2018; 73():15-24. PubMed ID: 29558672 [TBL] [Abstract][Full Text] [Related]
31. The effect of haloperidol on stuttering. Rosenberger PB; Wheelden JA; Kalotkin M Am J Psychiatry; 1976 Mar; 133(3):331-4. PubMed ID: 1259046 [TBL] [Abstract][Full Text] [Related]
32. Response of hemiballismus to haloperidol. Gilbert GJ JAMA; 1975 Aug; 233(6):535-6. PubMed ID: 1173667 [No Abstract] [Full Text] [Related]
33. An objective evaluation of haloperidol in Gilles de la Tourette's syndrome. Ford CV; Gottlieb F Dis Nerv Syst; 1969 May; 30(5):328-32. PubMed ID: 4890446 [No Abstract] [Full Text] [Related]
34. Higher than usual dosage of haloperidol: a pilot study in 'back ward' schizophrenics. Tanghe A; Declercq H Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):50-3. PubMed ID: 798191 [TBL] [Abstract][Full Text] [Related]
35. Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients. Chouinard G; Serrano PM; Tetreault L Curr Ther Res Clin Exp; 1973 Jul; 15(7):473-83. PubMed ID: 4198310 [No Abstract] [Full Text] [Related]
36. Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Di Salvo TG; O'Gara PT Clin Cardiol; 1995 May; 18(5):285-90. PubMed ID: 7628136 [TBL] [Abstract][Full Text] [Related]